| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.8M | $3.9M | $5.0M |
| YoY Revenue Growth % | -54.1% | -22.7% | — |
| Gross Profit | -$5.7M | -$1.5M | — |
| Gross Margin % | -50.0% | -37.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$28.0M | -$15.7M | -$12.5M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$29.5M | -$17.5M | -$14.3M |
| EBITDA (Normalized) | -$21.5M | -$9.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$18.2M | -$15.8M | -$11.7M |
| Capital Expenditures (CapEx) | $8.2M | $7.5M | — |
| Free Cash Flow (FCF) | -$26.3M | -$23.3M | -$11.7M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -43.7% | -45.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $50.6M | $23.5M | — |